KW-0761
Phase 1/2Completed 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Peripheral T-Cell Lymphoma
Conditions
Peripheral T-Cell Lymphoma
Trial Timeline
May 1, 2009 → Sep 1, 2012
NCT ID
NCT00888927About KW-0761
KW-0761 is a phase 1/2 stage product being developed by Kyowa Kirin for Peripheral T-Cell Lymphoma. The current trial status is completed. This product is registered under clinical trial identifier NCT00888927. Target conditions include Peripheral T-Cell Lymphoma.
What happened to similar drugs?
8 of 20 similar drugs in Peripheral T-Cell Lymphoma were approved
Approved (8) Terminated (2) Active (11)
Hype Score Breakdown
Clinical
9
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01192984 | Phase 2 | Completed |
| NCT01226472 | Phase 2 | Completed |
| NCT00920790 | Phase 2 | Completed |
| NCT00888927 | Phase 1/2 | Completed |
| NCT00355472 | Phase 1 | Completed |
Competing Products
20 competing products in Peripheral T-Cell Lymphoma